Dr. Gellad spoke with David Templeton of the Pittsburgh Post-Gazette regarding the treatment of individuals with Hepatitis C. Medications exist which can treat and cure a patient with Hepatitis C, unfortunately they come with a large price tag. The decision for many patients is made by Medicare and private health insurance providers, and out of their hands. Dr. Gellad speaks to the concern over exorbitant drug prices, early treatment, and screening. New treatments are coming available and the medical community is anxious to see how they are priced.